These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 18269104)

  • 1. Bad medicine in the market.
    Roger B; Boateng K
    World Hosp Health Serv; 2007; 43(3):17-21. PubMed ID: 18269104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Counterfeit medicines: a growing threat].
    Barbereau S
    Med Trop (Mars); 2006 Dec; 66(6):529-32. PubMed ID: 17286014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spurious and counterfeit drugs: a growing industry in the developing world.
    Gautam CS; Utreja A; Singal GL
    Postgrad Med J; 2009 May; 85(1003):251-6. PubMed ID: 19520877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substandard medicines in resource-poor settings: a problem that can no longer be ignored.
    Caudron JM; Ford N; Henkens M; Macé C; Kiddle-Monroe R; Pinel J
    Trop Med Int Health; 2008 Aug; 13(8):1062-72. PubMed ID: 18631318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substandard and counterfeit antimicrobials: recent trends and implications to key public health interventions in developing countries.
    Tadeg H; Berhane Y
    East Afr J Public Health; 2012 Jun; 9(2):85-9. PubMed ID: 23139963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Update on counterfeit drugs: a growing risk for public health].
    Juillet Y
    Bull Acad Natl Med; 2008 Oct; 192(7):1423-34; discussion 1434-6. PubMed ID: 19445366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Problems associated with substandard and counterfeit drugs in developing countries: a review article on global implications of counterfeit drugs in the era of antiretroviral (ARVs) drugs in a free market economy.
    Nsimba SE
    East Afr J Public Health; 2008 Dec; 5(3):205-10. PubMed ID: 19374325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deterring the importation of counterfeit pharmaceutical products.
    Stearn DW
    Food Drug Law J; 2004; 59(4):537-61. PubMed ID: 15875351
    [No Abstract]   [Full Text] [Related]  

  • 9. [Are there counterfeit medicines in Croatia?].
    Tomić S; Milcić N; Sokolić M; Sucić AF; Martinac AI
    Lijec Vjesn; 2010; 132(3-4):81-6. PubMed ID: 20540433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beef up international cooperation on counterfeits.
    Shepherd M
    Nat Med; 2010 Apr; 16(4):366. PubMed ID: 20376036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organ Tech Rep Ser; 1999; 885():i-vi, 1-156. PubMed ID: 10352573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Quality of medicines in least developed countries].
    Videau JY
    Med Trop (Mars); 2006 Dec; 66(6):533-7. PubMed ID: 17286015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The fight against counterfeit medicines in Africa: experience and role of pharmacists].
    Chauvé M
    C R Biol; 2008 Dec; 331(12):982-5. PubMed ID: 19027699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Counterfeit drugs.
    Rudolf PM; Bernstein IB
    N Engl J Med; 2004 Apr; 350(14):1384-6. PubMed ID: 15070787
    [No Abstract]   [Full Text] [Related]  

  • 15. [The drug trade between European countries and developing countries].
    Bruneton C; Naboulet P; van der Heide B; Rey JL
    Med Trop (Mars); 1997; 57(4):375-9. PubMed ID: 9612781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Counterfeit drugs in Israel and worldwide. Part II: distribution profile and anti-counterfeiting strategies and actions].
    Furman-Assaf S; Tamir O; Marom E; Arieli M; Shemer J
    Harefuah; 2010 Jul; 149(7):470-5, 479. PubMed ID: 21465764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Counterfeits kill!
    Ghebrehiwet T
    Imprint; 2006; 53(3):40-4. PubMed ID: 16821529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does price reveal poor-quality drugs? Evidence from 17 countries.
    Bate R; Jin GZ; Mathur A
    J Health Econ; 2011 Dec; 30(6):1150-63. PubMed ID: 21917346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaceutical counterfeiting.
    Deisingh AK
    Analyst; 2005 Mar; 130(3):271-9. PubMed ID: 15724152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fake malaria drugs].
    Bygbjerg IC
    Ugeskr Laeger; 2009 Mar; 171(10):815-7. PubMed ID: 19265610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.